- conflicts or gaps
- [[{"field": {"value": "identity.founded_year", "source_urls": ["https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://www.cbinsights.com/company/circumvent-pharmaceuticals"]}, "conflict": {"value": "Founded year reported as 2015 (Tracxn) vs 2017 (Inknowvation, CB Insights, Golden).", "source_urls": ["https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://www.cbinsights.com/company/circumvent-pharmaceuticals", "https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG"]}}, {"field": {"value": "founders.roster", "source_urls": ["https://www.ycombinator.com/companies/circumvent", "https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG"]}, "conflict": {"value": "YC lists only Devin Wiley as Founder; Golden, Inknowvation, Tracxn, and company site also associate Andrew Lim as co-founder/CEO.", "source_urls": ["https://www.ycombinator.com/companies/circumvent", "https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU", "https://www.circumventpharmaceuticals.com/"]}}, {"field": {"value": "founders.andrew_lim_status", "source_urls": ["https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU"]}, "conflict": {"value": "2019 SBIR profile lists Andrew Lim as CEO; Tracxn (May 2026) lists him as Former Co-Founder.", "source_urls": ["https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU", "https://www.circumventpharmaceuticals.com/"]}}, {"field": {"value": "identity.yc_batch", "source_urls": ["https://www.ycombinator.com/companies/circumvent", "https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG"]}, "conflict": {"value": "Golden wiki incorrectly references Y Combinator W19 Demo Day; primary sources place company in Summer 2018 (S18) batch.", "source_urls": ["https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG", "https://www.ycombinator.com/companies/circumvent", "https://yc-oss.github.io/api/batches/summer-2018/circumvent.json"]}}, {"field": {"value": "identity.hq_location", "source_urls": ["https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc"]}, "conflict": {"value": "Golden lists both Pasadena, California and Portland, Oregon; SBIR profile and company site list Portland, Oregon only.", "source_urls": ["https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://www.circumventpharmaceuticals.com/"]}}, {"field": {"value": "funding.total_funding", "source_urls": ["https://www.cbinsights.com/company/circumvent-pharmaceuticals/financials", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU"]}, "conflict": {"value": "CB Insights reports $150K total venture funding (YC only); Inknowvation documents $3,902,529 in NIH SBIR awards; Tracxn reports $150K across 5 rounds mixing grants and seed. Non-government investors (YC Bio, Heritage Provider Network, Longevity Fund) cited without disclosed amounts.", "source_urls": ["https://www.cbinsights.com/company/circumvent-pharmaceuticals/financials", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU", "https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG"]}}, {"field": {"value": "employees.headcount", "source_urls": ["https://www.ycombinator.com/companies/circumvent", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU"]}, "conflict": {"value": "Headcount ranges from 4 (Jul 2021 legal entity) to 6 (YC) to 5-9 (2019 SBIR) to 8 (Apr 2026 Tracxn); no current official count from company.", "source_urls": ["https://www.ycombinator.com/companies/circumvent", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU", "https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG"]}}, {"field": {"value": "products.approved_therapies", "source_urls": ["https://www.circumventpharmaceuticals.com/"]}, "gap": {"value": "No FDA-approved products; company states no approved treatments exist for CLN1 Batten disease and its programs remain preclinical.", "source_urls": ["https://www.circumventpharmaceuticals.com/", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc"]}}, {"field": {"value": "funding.non_yc_investor_amounts", "source_urls": ["https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG"]}, "gap": {"value": "No primary-source disclosure found for equity/debt round sizes from YC Bio, Heritage Provider Network, Longevity Fund, or Center for Advancing Innovation.", "source_urls": ["https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG"]}}, {"field": {"value": "exit_status.valuation_revenue", "source_urls": ["https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc"]}, "gap": {"value": "No public valuation; Tracxn cites annual revenue $0-$1M as of Dec 31, 2020; Inknowvation (2019) cites revenue range $0.5M-$1M — both third-party estimates.", "source_urls": ["https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc"]}}]]
- source urls
- ["https://golden.com/wiki/Circumvent_Pharmaceuticals-MN4WKAG", "https://tracxn.com/d/companies/circumventpharmaceuticals/__TALCENTUpRzcMGxx0Nkp5mU86bHikue3DYZZclkJfbU", "https://www.cbinsights.com/company/circumvent-pharmaceuticals", "https://www.cbinsights.com/company/circumvent-pharmaceuticals/financials", "https://www.circumventpharmaceuticals.com/", "https://www.inknowvation.com/sbir/companies/circumvent-pharmaceuticals-inc", "https://www.ycombinator.com/companies/circumvent", "https://yc-oss.github.io/api/batches/summer-2018/circumvent.json"]